Clearbridge Investments, LLC Amicus Therapeutics, Inc. Transaction History

Clearbridge Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $25.2 Million - $31 Million	-2,894,879 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $205,353 - $532,579	-22,321 Reduced 0.77%	2,894,879 $28.6 Million
Q4 2020 Feb 10, 2021	SELL	$13.47 - $24.89 $17.8 Million - $32.9 Million	-1,320,992 Reduced 31.17%	2,917,200 $67.4 Million
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $3.19 Million - $3.93 Million	247,103 Added 6.19%	4,238,192 $59.8 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $2.12 Million - $3.76 Million	239,518 Added 6.38%	3,991,089 $60.2 Million
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $24.9 Million - $41.9 Million	3,751,571 New	3,751,571 $34.7 Million

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.73B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.